Rossi Mariateresa

15PUBLICATIONS
92CO-AUTHORS
AllergyChemical thermodynamics and energeticsPredictive and prognostic markersBiomaterialsEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 22, 2026
Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area.

|Apr 20, 2026
Eccrine Squamous Syringometaplasia Mimicking Acute Cutaneous GVHD in a Pediatric HSCT Recipient: Case Report and Brief Review of the Indexed Literature.

|Apr 15, 2026
Efficacy and Safety of Abrocitinib for Moderate-to-severe Atopic Dermatitis in Adults: A 52-week Real-world Multicentre StudyIL-AD (Italian Landscape Atopic Dermatitis).

Elena Pezzolo, Rossi Mariateresa, Raul Armando Luyo Saboya

|Mar 17, 2026
Predictors of Response to Topical Ruxolitinib in Non-segmental Vitiligo: A Narrative Review.

Luca Bettolini, Vincenzo Maione, Andrea Carugno

|Jan 03, 2026
Pro-Inflammatory Signaling in Dermal Fibroblasts: A Possible Role of Different Botulinum Toxin Formulations on IL-6 Expression.

Sabrina Sommatis, Roberto Mocchi, Serena Di Francesco

|Oct 10, 2025
Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study.

Gianluca Avallone, Andrea Bombelli, Luigi Gargiulo

Pageof 3

Frequent Collaborators

8 joint publications

Silvia Mariel Ferrucci

8 joint publications

Maddalena Napolitano

7 joint publications

Chiara Palladino

7 joint publications

Simone Ribero